Sell-Side Advisory for Owners & Sponsors
Position the asset on operating reality, not optimistic narrative.
Ideal clients
- Owners and sponsors
- Boards
- Health systems divesting assets
- Sellers in distressed processes
Typical outcomes
- A defensible equity story grounded in operating data
- Fewer surprises in diligence, fewer re-trades at close
- A process that does not consume the management team
Selling a proton center is not a normal healthcare M&A process. The buyer universe is narrow, the diligence is technical, and the story has to hold up to operators, not just bankers. We help owners position the asset on operating reality, then defend it through diligence.
We work with owners, sponsors, and boards preparing a center, portfolio, or related infrastructure platform for sale, refinancing, or strategic transaction. The earlier we are involved, the more pricing and structure we can protect.
Our role is operator translation: shaping the equity story, anticipating the diligence questions a credible buyer will actually ask, and keeping management focused on running the asset while the process runs.
Sample scope
- Sale readiness assessment and gap remediation
- Equity story, narrative, and CIM input
- Operational and clinical diligence preparation
- Buyer landscape mapping and outreach support
- Management preparation for diligence and meetings
- Negotiation and structuring input alongside bankers and counsel
What is your practice actually worth?
A directional read using the same triangulation a credible buyer will run. Adjust the inputs to your situation, equipment age in particular reshapes the range.
Triangulate what your practice is worth, on operating reality.
We blend two industry-standard methods, EBITDA multiple and revenue multiple, then compress the range for equipment age. This is how a credible buyer actually frames the bid.
Equipment age impact
Multiples compressed by 7%, buyers price near-term capex into the bid.
Composite enterprise value
$53.9M – $85.1M
Equity to seller: $35.9M – $67.1M after $18.0M net debt (debt − cash).
6.0×–8.8× on $9.5M EBITDA
1.2×–2.3× on $38.0M revenue
Weighted blend: 65% EBITDA, 35% revenue.
Indicative only. Real bids depend on payer mix, referral durability, accelerator vendor, JV structure, and the credibility of forward EBITDA. We pressure-test all of these before going to market.
Often engaged in combination.
Feasibility Analysis
Get the foundational decisions right before they become expensive to undo.
Turnaround Services
Centers do not need a new strategy deck. They need someone who has lived inside one.
Growth & Referral Development
Centers do not fail because the technology underperforms. They fail because volume never shows up.
Most engagements start with a single, focused conversation.
Tell us where the situation is, and we'll tell you whether we're the right firm for it.